Key Points
- CEO Oguzhan Atay sold 5,150 Billiontoone shares for approximately $516,185 under a pre-arranged Rule 10b5-1 trading plan, reducing his position by 61.8% to 3,183 shares.
- BLLN shares fell 4.5% to $98.12, giving the company a market capitalization of about $4.63 billion; its latest quarterly earnings matched expectations at $0.15 per share on $109.45 million in revenue.
- Analysts maintain a “Moderate Buy” consensus, with seven Buy, three Hold, and one Sell rating and an average price target of $126.25.
Billiontoone, Inc. (NASDAQ:BLLN - Get Free Report) CEO Oguzhan Atay sold 5,150 shares of Billiontoone stock in a transaction on Thursday, October 15th. The shares were sold at an average price of $100.23, for a total value of $516,184.50. Following the transaction, the chief executive officer owned 3,183 shares of the company's stock, valued at $319,032.09. The trade was a 61.80% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Oguzhan Atay also recently made the following trade(s):
- On Wednesday, October 14th, Oguzhan Atay sold 2,667 shares of Billiontoone stock. The stock was sold at an average price of $98.00, for a total value of $261,366.00.
- On Wednesday, October 14th, Oguzhan Atay sold 3,183 shares of Billiontoone stock. The stock was sold at an average price of $98.34, for a total value of $313,016.22.
- On Monday, October 12th, Oguzhan Atay sold 2,667 shares of Billiontoone stock. The shares were sold at an average price of $97.61, for a total value of $260,325.87.
- On Monday, October 12th, Oguzhan Atay sold 16,667 shares of Billiontoone stock. The shares were sold at an average price of $93.79, for a total value of $1,563,197.93.
- On Monday, September 28th, Oguzhan Atay sold 2,666 shares of Billiontoone stock. The stock was sold at an average price of $120.64, for a total value of $321,626.24.
- On Monday, September 28th, Oguzhan Atay sold 8,333 shares of Billiontoone stock. The stock was sold at an average price of $120.64, for a total value of $1,005,293.12.
- On Monday, September 14th, Oguzhan Atay sold 5,332 shares of Billiontoone stock. The stock was sold at an average price of $98.00, for a total transaction of $522,536.00.
- On Monday, September 14th, Oguzhan Atay sold 24,999 shares of Billiontoone stock. The shares were sold at an average price of $100.32, for a total transaction of $2,507,899.68.
- On Monday, August 3rd, Oguzhan Atay sold 12,500 shares of Billiontoone stock. The shares were sold at an average price of $137.37, for a total transaction of $1,717,125.00.
- On Monday, August 3rd, Oguzhan Atay sold 32,500 shares of Billiontoone stock. The shares were sold at an average price of $136.95, for a total transaction of $4,450,875.00.
Billiontoone Stock Down 4.5%
NASDAQ:BLLN traded down $4.61 on Friday, reaching $98.12. 605,635 shares of the stock traded hands, compared to its average volume of 654,157. The company has a market capitalization of $4.63 billion and a price-to-earnings ratio of 140.17. The company has a current ratio of 11.69, a quick ratio of 11.31 and a debt-to-equity ratio of 0.17. Billiontoone, Inc. has a 12 month low of $61.96 and a 12 month high of $150.44. The company's fifty day simple moving average is $100.99 and its 200 day simple moving average is $101.58.
Billiontoone (NASDAQ:BLLN - Get Free Report) last issued its earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.15. The business had revenue of $109.45 million during the quarter. Billiontoone had a net margin of 8.04% and a return on equity of 9.96%. Equities analysts predict that Billiontoone, Inc. will post 0.80 EPS for the current fiscal year.
Analyst Ratings Changes
A number of equities analysts recently weighed in on the stock. Weiss Ratings lowered shares of Billiontoone from a "sell (d+)" rating to a "sell (d)" rating in a report on Thursday, October 8th. Zacks Research upgraded Billiontoone from a "strong sell" rating to a "hold" rating in a research note on Friday, October 2nd. JPMorgan Chase & Co. cut their target price on Billiontoone from $145.00 to $130.00 and set an "overweight" rating on the stock in a research note on Thursday, August 6th. Canaccord Genuity Group began coverage on Billiontoone in a report on Wednesday, September 2nd. They issued a "buy" rating and a $120.00 target price for the company. Finally, Guggenheim boosted their price target on Billiontoone from $125.00 to $128.00 and gave the stock a "buy" rating in a research note on Thursday, October 1st. Seven analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $126.25.
Read Our Latest Stock Report on BLLN
Institutional Trading of Billiontoone
A number of institutional investors have recently made changes to their positions in the stock. Wasatch Advisors LP grew its stake in shares of Billiontoone by 40.2% in the second quarter. Wasatch Advisors LP now owns 518,084 shares of the company's stock worth $62,160,000 after acquiring an additional 148,446 shares during the period. Emerald Advisers LLC raised its holdings in shares of Billiontoone by 26.8% during the first quarter. Emerald Advisers LLC now owns 239,562 shares of the company's stock valued at $18,911,000 after purchasing an additional 50,613 shares during the last quarter. Emerald Mutual Fund Advisers Trust raised its holdings in shares of Billiontoone by 11.9% during the first quarter. Emerald Mutual Fund Advisers Trust now owns 132,206 shares of the company's stock valued at $10,436,000 after purchasing an additional 14,072 shares during the last quarter. Perceptive Advisors LLC lifted its position in Billiontoone by 26.1% during the first quarter. Perceptive Advisors LLC now owns 91,812 shares of the company's stock valued at $7,248,000 after purchasing an additional 19,000 shares during the period. Finally, Renaissance Technologies LLC bought a new position in Billiontoone during the first quarter valued at approximately $4,046,000.
About Billiontoone
(
Get Free Report)
BillionToOne, Inc (NASDAQ:BLLN) is a molecular diagnostics company that develops blood-based genetic tests designed to provide more information from small amounts of cell-free DNA. The company's platform uses proprietary molecular counting technology to improve the sensitivity and accuracy of diagnostic testing.
BillionToOne's primary business is reproductive health testing. Its UNITY portfolio is designed to support prenatal screening, including testing for chromosomal conditions and single-gene disorders, and is intended to provide physicians and expectant parents with information from a maternal blood sample.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
